This Article Full Text Full Text (PDF) All Versions of this Article: 116/19/2127    most recent CIRCULATIONAHA.107.704197v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bujak, M. Articles by Frangogiannis, N. G. Search for Related Content PubMed PubMed Citation Articles by Bujak, M. Articles by Frangogiannis, N. G. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Heart Attack Related Collections Remodeling Animal models of human disease Growth factors/cytokines Ischemic biology - basic studies

(Circulation. 2007;116:2127-2138.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling

Marcin Bujak, MD; Guofeng Ren, PhD; Hyuk Jung Kweon, MD; Marcin Dobaczewski, MD; Anilkumar Reddy, PhD; George Taffet, MD; Xiao-Fan Wang, PhD; Nikolaos G. Frangogiannis, MD

From the Section of Cardiovascular Sciences (M.B., G.R., H.J.K., M.D., A.R., G.T., N.G.F.), Baylor College of Medicine, Houston, Tex, and Department of Pharmacology and Cancer Biology (X.-F.W.), Duke University, Durham, NC.

Correspondence to Nikolaos G. Frangogiannis, MD, Section of Cardiovascular Sciences, One Baylor Plaza M/S BCM620, Baylor College of Medicine, Houston, TX 77030. E-mail ngf{at}bcm.tmc.edu

Received March 19, 2007; accepted August 17, 2007.

Background— Postinfarction cardiac repair is regulated through timely activation and repression of inflammatory pathways, followed by transition to fibrous tissue deposition and formation of a scar. The transforming growth factor-ß/Smad3 pathway is activated in healing infarcts and may regulate cellular events critical for the inflammatory and the fibrotic responses.

Methods and Results— We examined the effects of Smad3 gene disruption on infarct healing and the pathogenesis of cardiac remodeling. In the absence of injury, Smad3-null hearts had comparable function to and similar morphology as wild-type hearts. Smad3-null animals had suppressed peak chemokine expression and decreased neutrophil recruitment in the infarcted myocardium but showed timely repression of inflammatory gene synthesis and resolution of the inflammatory infiltrate. Although myofibroblast density was higher in Smad3-null infarcts, interstitial deposition of collagen and tenascin-C in the remodeling myocardium was markedly reduced. Compared with wild-type animals, Smad3^–/– mice exhibited decreased dilative remodeling and attenuated diastolic dysfunction; however, infarct size was comparable between groups. Transforming growth factor-ß–mediated induction of procollagen type III and tenascin-C in isolated cardiac fibroblasts was dependent on Smad3, which suggests that decreased fibrotic remodeling in infarcted Smad3-null hearts may be due to abrogation of the profibrotic transforming growth factor-ß responses.

Conclusions— Smad3 loss does not alter the time course of resolution of inflammation in healing infarcts, but it prevents interstitial fibrosis in the noninfarcted myocardium and attenuates cardiac remodeling. Thus, the Smad3 cascade may be a promising therapeutic target for the treatment of myocardial infarction.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling Am. J. Pathol., July 1, 2008; 173(1): 57 - 67. [Abstract] [Full Text] [PDF]

				J. W.K. Ho, M. Stefani, C. G. dos Remedios, and M. A. Charleston Differential variability analysis of gene expression and its application to human diseases Bioinformatics, July 1, 2008; 24(13): i390 - i398. [Abstract] [PDF]

				U. Yokoyama, H. H. Patel, N. C. Lai, N. Aroonsakool, D. M. Roth, and P. A. Insel The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals PNAS, April 29, 2008; 105(17): 6386 - 6391. [Abstract] [Full Text] [PDF]

				P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N. G. Frangogiannis CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response J. Immunol., February 15, 2008; 180(4): 2625 - 2633. [Abstract] [Full Text] [PDF]

				D. Seo and J. M. Hare The Transforming Growth Factor-{beta}/Smad3 Pathway: Coming of Age as a Key Participant in Cardiac Remodeling Circulation, November 6, 2007; 116(19): 2096 - 2098. [Full Text] [PDF]